Anixa Biosciences Inc.

NASDAQ: ANIX · Real-Time Price · USD
2.97
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
2.97
0.00%
After-hours: Aug 15, 2025, 07:56 PM EDT

Anixa Biosciences Income Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021
Revenue
n/a n/a n/a 156K 156K 366K 366K 2.47B 2.47B 2.47B 2.47B 3.61M 3.61M 3.61M 4.13M 388.14K 388.14K 388.14K
Cost of Revenue
n/a 12K 25K 37K 48K 197K 195K 194K 193K 43K 42K 416K 421.17K 424.8K 799.8K 539.16K 524K 509.36K
Gross Profit
-3K -15K -28K 116K 108K 169K 171K 2.47B 2.47B 2.47B 2.47B 3.2M 3.19M 3.19M 3.33M -151.02K -135.86K -121.22K
Operating Income
-13.14M -13.61M -13.83M -13.72M -12.97M -12.06M -11.01M -11.57M -11.52M -12.55M -13.88M -14.34M -15.93M -14.78M -13.14M -11.3M -9.35M -9.58M
Interest Income
890K 987K 1.13M 1.21M 1.23M 1.2M 1.08M 831K 557K 305K 104K 24.55K 3.17K 2.57K 2.57K 3.23K 9.88K 21.63K
Pretax Income
-12.25M -12.62M -12.7M -12.51M -11.74M -10.87M -9.93M -10.74M -10.96M -12.25M -13.77M -14.31M -15.93M -14.77M -13.13M -11.3M -9.49M -9.71M
Net Income
-12.13M -12.48M -12.55M -12.36M -11.6M -10.49M -9.36M -10.06M -10.25M -11.76M -13.47M -14.09M -15.72M -14.58M -12.95M -11.17M -9.39M -9.63M
Selling & General & Admin
6.87M 7M 7.41M 7.16M 7.25M 7.05M 6.29M 6.78M 6.38M 6.62M 7.17M 7.15M 8.02M 7.58M 7.07M 5.75M 5.11M 5.14M
Research & Development
6.28M 6.6M 6.4M 6.54M 5.7M 5.05M 4.77M 4.84M 5.2M 5.93M 6.7M 7.19M 7.91M 7.2M 6.19M 5.67M 4.37M 4.57M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
13.14M 13.6M 13.81M 13.69M 12.95M 12.1M 11.06M 11.62M 11.57M 12.55M 13.88M 14.34M 15.93M 14.78M 13.26M 11.43M 9.48M 9.71M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 626.00 1.02K 1.02K 1.02K 393.00 n/a
Selling & Marketing Expenses
n/a -12K -25K -25K -25K -13K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
13.14M 13.61M 13.83M 13.72M 12.97M 12.27M 11.22M 11.78M 11.73M 12.55M 13.88M 14.34M 15.93M 14.78M 13.65M 11.81M 9.86M 10.09M
Income Tax Expense
n/a n/a n/a n/a n/a -272K -506K -639K -712K -440K -206K -73K -54.87K -93.7K -119.29K -119.29K -64.42K -25.59K
Shares Outstanding (Basic)
32.2M 32.2M 31.9M 32.05M 31.91M 31.45M 31.08M 30.97M 30.93M 30.92M 30.76M 30.45M 30.15M 30.13M 30.05M 30.45M 28.67M 25.16M
Shares Outstanding (Diluted)
32.2M 32.2M 31.9M 32.05M 31.91M 31.45M 31.08M 30.97M 30.93M 30.92M 30.76M 30.45M 30.15M 30.13M 30.13M 30.45M 28.67M 25.16M
EPS (Basic)
0.01 0.00 0.00 -0.38 -0.37 -0.33 -0.3 -0.33 -0.33 -0.39 -0.45 -0.47 -0.52 -0.48 -0.44 -0.4 -0.37 -0.41
EPS (Diluted)
0.01 0.00 0.00 -0.38 -0.37 -0.33 -0.3 -0.33 -0.33 -0.39 -0.45 -0.47 -0.52 -0.48 -0.44 -0.4 -0.37 -0.41
EBITDA
-13.12M -13.6M -13.82M -13.37M -12.63M -11.72M -10.67M -11.48M -11.4M -12.42M -13.73M -14.27M -15.87M -14.72M -13.07M -11.24M -9.31M -9.54M
EBIT
-13.14M -13.61M -13.83M -13.72M -12.97M -12.06M -11.01M -11.57M -11.52M -12.55M -13.88M -14.34M -15.93M -14.78M -13.14M -11.3M -9.35M -9.58M
Depreciation & Amortization
21K 24K 37K 40K 48K 48K 46K 45K 44K 43K 42K 46.94K 52.1K 55.74K 59.74K 57.37K 64.32K 76.84K